Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Axogen Inc (AXGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 686,694
  • Shares Outstanding, K 38,323
  • Annual Sales, $ 60,430 K
  • Annual Income, $ -10,450 K
  • 36-Month Beta 0.10
  • Price/Sales 8.30
  • Price/Cash Flow N/A
  • Price/Book 4.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.54 +20.84%
on 01/17/19
18.56 -5.33%
on 02/11/19
+0.96 (+5.78%)
since 01/15/19
3-Month
14.13 +24.35%
on 01/09/19
35.11 -49.96%
on 12/03/18
-15.42 (-46.74%)
since 11/15/18
52-Week
14.13 +24.35%
on 01/09/19
56.85 -69.09%
on 07/24/18
-9.83 (-35.88%)
since 02/15/18

Most Recent Stories

More News
CLASS ACTION UPDATE for PRGO, AXGN, YRIV and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

AXGN : 17.57 (-1.95%)
W : 122.11 (+1.69%)
PRGO : 48.95 (+0.72%)
YRIV : 0.40 (-22.33%)
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AxoGen, Inc. (AXGN) & Lead Plaintiff Deadline - March 11, 2019

NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ:...

AXGN : 17.57 (-1.95%)
SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AxoGen, Inc. (AXGN) & Lead Plaintiff Deadline - March 11, 2019

NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against AxoGen, Inc. ("AxoGen" or the ''Company") (NASDAQ:...

AXGN : 17.57 (-1.95%)
AxoGen, Inc. (AXGN), Wayfair Inc. (W) and Markel Corporation (MKL) Bronstein, Gewirtz & Grossman, LLC Class Action Update

NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can...

AXGN : 17.57 (-1.95%)
W : 122.11 (+1.69%)
MKL : 1,009.80 (-0.06%)
Danske Bank A/S (DNKEY), AxoGen, Inc. (AXGN) and Wayfair Inc. (W) - Bronstein, Gewirtz & Grossman, LLC Class Action Update

NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review...

AXGN : 17.57 (-1.95%)
DNKEY : 9.3500 (+2.19%)
W : 122.11 (+1.69%)
CLASS ACTION UPDATE for XRAY, AXGN and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

AXGN : 17.57 (-1.95%)
XRAY : 43.58 (-0.23%)
MAXR : 6.02 (+0.33%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AXGN, W and WRCDF, WCAGY

The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies...

AXGN : 17.57 (-1.95%)
W : 122.11 (+1.69%)
WRCDF : 110.7500 (-6.14%)
WCAGY : 56.4850 (-2.54%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AxoGen, Inc. (AXGN) & Lead Plaintiff Deadline - March 11, 2019

NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against AxoGen, Inc. ("AxoGen" or the ''Company") (NASDAQ:...

AXGN : 17.57 (-1.95%)
Recent Analysis Shows Lattice Semiconductor, ZIOPHARM Oncology, Ferro, SYNNEX, AxoGen, and Twin Disc Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Lattice Semiconductor Corporation...

AXGN : 17.57 (-1.95%)
LSCC : 11.08 (-3.65%)
ZIOP : 2.59 (+0.78%)
SNX : 101.60 (+0.35%)
FOE : 17.40 (+2.90%)
TWIN : 17.50 (+3.18%)
Axogen, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26, 2019

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that it will report fourth quarter...

AXGN : 17.57 (-1.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade AXGN with:

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

2nd Resistance Point 18.55
1st Resistance Point 18.06
Last Price 17.57
1st Support Level 17.26
2nd Support Level 16.96

See More

52-Week High 56.85
Fibonacci 61.8% 40.53
Fibonacci 50% 35.49
Fibonacci 38.2% 30.45
Last Price 17.57
52-Week Low 14.13

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar